MedMira Announces Launch of Clinical Trial for Its Multiplo® TP/HIV Self-Test in Canada
MedMira Inc. (MedMira) (TSXV: MIR) and REACH Nexus are excited to announce a clinical trial has officially started earlier than anticipated to evaluate MedMira’s Multiplo® TP/HIV rapid test for use as a self-test in Canada. MedMira has been able to Mehr







